{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:25:20Z","timestamp":1790925920069,"version":"4.1.0"},"reference-count":38,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.3892\/ijo.2013.2192","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T05:57:08Z","timestamp":1385618228000},"page":"377-384","source":"Crossref","is-referenced-by-count":21,"title":["Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL"],"prefix":"10.3892","volume":"44","author":[{"given":"TAKEO","family":"TATSUTA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAHIRO","family":"HOSONO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOHTA","family":"TAKAHASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKASHI","family":"OMOTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUKIKO","family":"KARIYA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIGEKI","family":"SUGAWARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SENITIROH","family":"HAKOMORI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUO","family":"NITTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,11,28]]},"reference":[{"key":"key20180107182545_b1-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1357-2725(03)00242-5","article-title":"The mesothelial cell","volume":"36","author":"Mutsaers","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107182545_b2-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.biocel.2006.07.002","article-title":"Human malignant mesothelioma: molecular mechanisms of pathogenesis and progression","volume":"38","author":"Spugnini","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107182545_b3-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/bjc.2011.563","article-title":"Estimating the asbestos-related lung cancer burden from mesothelioma mortality","volume":"106","author":"McCormack","year":"2012","journal-title":"Br J Cancer"},{"key":"key20180107182545_b4-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semdp.2006.08.002","article-title":"The pathogenesis of mesothelioma","volume":"23","author":"Carbone","year":"2006","journal-title":"Semin Diagn Pathol"},{"key":"key20180107182545_b5-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1378\/chest.113.1_Supplement.61S","article-title":"Multimodality management of malignant pleural mesothelioma","volume":"113","author":"Sugarbaker","year":"1998","journal-title":"Chest"},{"key":"key20180107182545_b6-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0169-5002(01)00257-4","article-title":"Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma","volume":"34","author":"Ceresoli","year":"2001","journal-title":"Lung Cancer"},{"key":"key20180107182545_b7-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ajpath.2012.12.028","article-title":"New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas","volume":"182","author":"Mossman","year":"2013","journal-title":"Am J Pathol"},{"key":"key20180107182545_b8-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ctrv.2009.09.003","article-title":"Second-line treatment for malignant pleural mesothelioma","volume":"36","author":"Ceresoli","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"key20180107182545_b9-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/prep.1996.0027","article-title":"Large-scale preparation of a ribonuclease from Rana catesbeiana (bullfrog) oocytes and characterization of its specific cytotoxic activity against tumor cells","volume":"7","author":"Liao","year":"1996","journal-title":"Protein Expr Purif"},{"key":"key20180107182545_b10-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1093\/nar\/28.21.4097","article-title":"Purification and cloning of cytotoxic ribonucleases from Rana catesbeiana (bullfrog)","volume":"28","author":"Liao","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"key20180107182545_b11-ijo-44-02-0377","first-page":"920","article-title":"Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily","volume":"54","author":"Nitta","year":"1994","journal-title":"Cancer Res"},{"key":"key20180107182545_b12-ijo-44-02-0377","first-page":"928","article-title":"Characterization of a Rana catesbeiana lectin-resistant mutant of leukemia P388 cells","volume":"54","author":"Nitta","year":"1994","journal-title":"Cancer Res"},{"key":"key20180107182545_b13-ijo-44-02-0377","first-page":"19","article-title":"Catalytic lectin (leczyme) from bullfrog (Rana catesbeiana) eggs","volume":"9","author":"Nitta","year":"1996","journal-title":"Int J Oncol"},{"key":"key20180107182545_b14-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0076-6879(01)41164-5","article-title":"Leczyme","volume":"341","author":"Nitta","year":"2001","journal-title":"Methods Enzymol"},{"key":"key20180107182545_b15-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3892\/ijo.2013.2092","article-title":"Sialic acid-binding lectin (leczyme) induces caspase-dependent apoptosis-mediated mitochondrial perturbation in Jurkat cells","volume":"43","author":"Tatsuta","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107182545_b16-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3892\/ijo.2013.2128","article-title":"Involvement of ER stress in apoptosis induced by sialic acid-binding lectin (leczyme) from bullfrog eggs","volume":"43","author":"Tatsuta","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107182545_b17-ijo-44-02-0377","first-page":"4877","article-title":"Isolation and characterization of Rana catesbeiana lectin and demonstration of the lectin-binding glycoprotein of rodent and human tumor cell membranes","volume":"47","author":"Nitta","year":"1987","journal-title":"Cancer Res"},{"key":"key20180107182545_b18-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"key20180107182545_b19-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrc821","article-title":"Targeting death and decoy receptors of the tumour-necrosis factor superfamily","volume":"2","author":"Ashkenazi","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107182545_b20-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.276.5309.111","article-title":"The receptor for the cytotoxic ligand TRAIL","volume":"276","author":"Pan","year":"1997","journal-title":"Science"},{"key":"key20180107182545_b21-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1074-7613(00)80400-8","article-title":"Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway","volume":"7","author":"Chaudhary","year":"1997","journal-title":"Immunity"},{"key":"key20180107182545_b22-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01922588","article-title":"Agglutinins of frog eggs: a new class of proteins causing preferential agglutination of tumor cells","volume":"31","author":"Kawauchi","year":"1975","journal-title":"Experientia"},{"key":"key20180107182545_b23-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1038\/sj.onc.1210134","article-title":"Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4","volume":"26","author":"Kurbanov","year":"2007","journal-title":"Oncogene"},{"key":"key20180107182545_b24-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.bjc.6605987","article-title":"A Phase 1b\/2 trial of mapatumumab in patients with relapsed\/refractory non-Hodgkin's lymphoma","volume":"103","author":"Younes","year":"2010","journal-title":"Br J Cancer"},{"key":"key20180107182545_b25-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1200\/JCO.2009.25.1991","article-title":"Phase I dose-escalation study of recombinant human Apo2L\/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer","volume":"28","author":"Herbst","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107182545_b26-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1200\/JCO.2011.37.2623","article-title":"Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer","volume":"29","author":"Soria","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20180107182545_b27-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/bjc.2011.84","article-title":"Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis","volume":"104","author":"Duiker","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180107182545_b28-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1165\/ajrcmb.25.1.4472","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines","volume":"25","author":"Liu","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key20180107182545_b29-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"key":"key20180107182545_b30-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/emboj\/17.6.1675","article-title":"Two CD95 (APO-1\/Fas) signaling pathways","volume":"17","author":"Scaffidi","year":"1998","journal-title":"EMBO J"},{"key":"key20180107182545_b31-ijo-44-02-0377","first-page":"1713","article-title":"Involvement of CPP32\/Yama(-like) proteases in Fas-mediated apoptosis","volume":"56","author":"Hasegawa","year":"1996","journal-title":"Cancer Res"},{"key":"key20180107182545_b32-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1073\/pnas.93.25.14486","article-title":"Molecular ordering of the Fas-apoptotic pathway: the Fas\/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3\/ICE-like cysteine proteases","volume":"93","author":"Srinivasula","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107182545_b33-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/sj.onc.1201131","article-title":"Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8","volume":"14","author":"Takahashi","year":"1997","journal-title":"Oncogene"},{"key":"key20180107182545_b34-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/0008-5472.CAN-06-3871","article-title":"Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1\/Akt pathway","volume":"67","author":"Pespeni","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107182545_b35-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"12486","DOI":"10.1074\/jbc.M408190200","article-title":"Bid mediates apoptotic synergy between tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and DNA damage","volume":"280","author":"Broaddus","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107182545_b36-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1158\/1535-7163.MCT-07-0278","article-title":"Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim","volume":"6","author":"Abayasiriwardana","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"key20180107182545_b37-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1535-7163.MCT-04-0260","article-title":"The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim","volume":"4","author":"Nikrad","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"key20180107182545_b38-ijo-44-02-0377","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.critrevonc.2012.08.001","article-title":"Bortezomib and TRAIL: a perfect match for apoptotic elimination of tumour cells?","volume":"85","author":"De Wilt","year":"2013","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.2192\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T19:11:08Z","timestamp":1647544268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.2192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,28]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,11,28]]},"published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.3892\/ijo.2013.2192"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.2192","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,28]]}}}